A U.S. Food and Drug Administration advisory committee on Thursday voted to approve Pfizer and BioNTech’s emergency use authorization (EUA) application for its coronavirus vaccine candidate, the first COVID-19 jab to win such approval in the U.S.
Health
December 11, 2020 at 04:38AM
0 Comments
Share your opinion